Abstract:A rapid, sensitive, selective, and accurate HPLC–MS/MS method was developed and validated for the simultaneous determination of chlorogenic acid, naucleactonin C, khaephuoside A 3,4-dimethoxyphenyl-1-O-β-apiofuroseyl(1 ⟶ 2)-β-D-glucopyranoside in rat plasma and tissues after oral administration of Nauclea officinalis extracts. Chloramphenicol was used as an internal standard (IS). The plasma and tissue samples were extracted by protein precipitation with methanol-ethyl acetate (1 : 1, v/v) including 0.1% (v/v) formic acid. The chromatographic separation was achieved by using an C18 column with gradient elution using mobile phase, which consisted of 0.1% formic acid water (A) and acetonitrile (B) and the flow rate of 0.8 mL/min. Mass spectrometric detection was performed in multiple reaction monitoring (MRM) mode utilizing electrospray ionization (ESI) in negative mode. The developed method exhibited good linearity (determination coefficients, R2 ≥ 0.9849), and the lower limits of quantification were 2, 5, 5, and 25 ng/mL for chlorogenic acid, naucleactonin C, khaephuoside A, and 3,4-dimethoxyphenyl-1-O-β-apiofuroseyl(1 ⟶ 2)-β-D-glucopyranoside. The intraday and interday precisions (relative standard deviation, RSD) were less than 12.65%, while the accuracy was ranged from 86.31 to 114.17%. The recovery rate were 51.85–97.06%, 75.99–106.68%, 77.46–105.35%, and 68.36–103.75% for chlorogenic acid, naucleactonin C, khaephuoside A, and 3,4-dimethoxyphenyl-1-O-β-apiofuroseyl(1 ⟶ 2)-β-D-glucopyranoside the matrix effects were 50.17–116.62%, 86.75–115.99%, 45.79–87.44%, and 51.60–92.34% for chlorogenic acid, naucleactonin C, khaephuoside A, and 3,4-dimethoxyphenyl-1-O-β-apiofuroseyl(1 ⟶ 2)-β-D-glucopyranoside in different matrix. The developed method was successfully applied to a pharmacokinetic study and tissue distribution of four compounds in rats after oral administration of Nauclea officinalis extracts.

Simultaneous quantification of niacin and its three main metabolites in human plasma by LC-MS/MS.

LC-MS–MS Simultaneous Determination of Niacin, Niacinamide and Nicotinuric Acid in Human Plasma LC-MS–MS and Its Application to a Human Pharmacokinetic Study

Quantification of Niacin and Its Metabolite Nicotinuric Acid in Human Plasma by Lc-Ms/Ms: Application to A Clinical Trial of A Fixed Dose Combination Tablet of Niacin Extended-Release/Simvastatin (500 Mg/10 Mg) in Healthy Chinese Volunteers

Development And Validation Of A Method For The Determination Of Nicotinic Acid In Human Plasma Using Liquid Chromatography-Negative Electrospray Ionization Tandem Mass Spectrometry And Its Application To A Bioequivalence Study

Simultaneous Quantification of Simvastatin and Simvastatin Acid in Human Plasma with a Highly Sensitive LC-ESI-MS/MS Method: Application to a Pharmacokinetic Study in Healthy Chinese Volunteers with a Fixed Dose of Simvastatin and Extended-Release Niacin Combination Tablet

Simultaneous Quantification of Sodium Ferulate, Salicylic Acid, Cinnarizine and Vitamin B1 in Human Plasma by LC Tandem MS Detection

Determination of newly synthesized lipoic acid-niacin dimer in rat plasma by UPLC/electrospray ionization tandem mass spectrometry: assay development, validation and application to a pharmacokinetic study.

A Rapid Method With Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry For Simultaneous Determination Of Five Type B Trichothecenes In Traditional Chinese Medicines

Selective, Sensitive and Simple LC–APCI–MS Method for the Quantitation of Alpha-Tocopheryl Nicotinate in Human Plasma

Simultaneous determination of Niacinamide, Vitamins B_6 and caffeine with Ion-pairing reversed phase high pressure liquid chromatography

Rapid and Simultaneous Determination of Nifedipine and Dehydronifedipine in Human Plasma by Liquid Chromatography–tandem Mass Spectrometry: Application to a Clinical Herb–drug Interaction Study

Absolute quantification of nicotinamide mononucleotide in biological samples by double isotope-mediated liquid chromatography-tandem mass spectrometry (dimeLC-MS/MS)

H PLC-MS/MS Method for Simultaneous Determination of Naringin and Naringenin in Human Plasma

Quantitative Determination of Nitrendipine in Human Plasma Using High-Performance Liquid Chromatography-Mass Spectrometry

Development and validation of an LC–MS/MS method for the quantitative analysis of the adenosine A2a receptor antagonist NIR178 and its monohydroxy metabolite in human plasma: Application to clinical pharmacokinetics

Simultaneous Determination of Nicotine and Its Nine Metabolites in Human Urine by LC–MS–MS

Simultaneous Determination of Rosuvastatin, Rosuvastatin-5 S-lactone, and N-desmethyl Rosuvastatin in Human Plasma by UPLC-MS/MS and Its Application to Clinical Study

Simultaneous determination of sibutramine and its N-desmethyl metabolites in human plasma by liquid chromatography–electrospray ionization–mass spectrometry Method and clinical applications

Development and validation of a sensitive liquid chromatography-tandem mass spectrometry method for the determination of naringin and its metabolite, naringenin, in human plasma.

Simultaneous Determination of GFA and Its Active Metabolites in Human Plasma by Liquid Chromatography Electrospray Ionization Mass Spectrometry and Its Application to Pharmacokinetic Studies

Measurement of Pharmacokinetics and Tissue Distribution of Four Compounds from Nauclea officinalis in Rat Plasma and Tissues through HPLC-MS/MS